Analytics Approach Could Improve Chemo Combinations

Share this content:
Analytics Approach Could Improve Chemo Combinations
Analytics Approach Could Improve Chemo Combinations

FRIDAY, May 6, 2016 (HealthDay News) -- Models based on machine learning and optimization could improve chemotherapy regimens to be tested in phase III clinical trials without altering the toxicity outcomes, according to a study published in the May issue of Management Science.

Dimitris Bertsimas, Ph.D., from Massachusetts Institute of Technology in Cambridge, and colleagues developed models to predict the outcomes of clinical trials testing combination chemotherapy regimens before they are run and to identify combination chemotherapy regimens to be tested in phase II and III trials. The models were developed in order to improve the quality of regimens tested in phase III trials.

The researchers built a database of 414 clinical trials for advanced gastric cancer. This was used to develop statistical models that could obtain an out-of-sample R² of 0.56 for predicting median overall survival and an out-of-sample area under the curve of 0.83 for predicting the unacceptability of high toxicity. Models were proposed that use machine learning and optimization to suggest regimens for phase II and III trials. Two techniques were used for estimating the quality of regimens selected by these models, compared with those tested in current clinical practice. Both techniques suggested that the models could improve the efficacy of the selected regimens for testing in phase III clinical trials, without altering toxicity outcomes.

"This evaluation of the proposed models suggests that they merit further testing in a clinical trial setting," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Factors ID'd to Predict Fatty Liver in Obese Teens

Factors ID'd to Predict Fatty Liver in Obese ...

African-American obese teens more susceptible to fatty liver effects on glucose metabolism

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients perceive F2F physicians as more compassionate and better communicators

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Absolute risks for colorectal cancer, CRC death not reduced for screening group vs. controls in women

is free, fast, and customized just for you!

Already a member?

Sign In Now »